Penumbra, Inc.

NYSE:PEN

Medical - Devices

Healthcare
$320.60 -0.72%

-$2.30 today

Market cap
$12.64B
Beta
0.70
P/E (TTM)
72.6
EPS (TTM)
$4.36
52W Low $221.26High $362.41

Volume 0.21M

Average 0.50M

PEN Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

Penumbra, Inc.NYSE: PEN

Common Stock · Q2 FY2026 · quarter ended Jun 2026

Common stock broadly unchanged from a year ago

Common stock stood at $39K at the end of Q2 FY2026, up 0.0% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +0.9% a year.

Context

  • Common stock amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Common stock increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether common stock keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$39K+0.0% QoQ
Last fiscal yearDec 2025
$39K+2.6% YoY
Year agoJun 2025
$39K+0.0% since
Common Stock past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.0%——
1 year+2.6%——
3-year CAGR+0.9%——
5-year CAGR——
10-year CAGR——

Common Stock history

USD · from the balance sheet

Latest · FY2025
39K USD
Year-over-year change
+2.6%
4-year CAGR
+1.3%

Common Stock vs competitors

How PEN compares with its peers on the latest reported figures

  • PEN's Jun 2026 common stock of $39K is the 8th highest of the 9 companies compared; the peer median is $8.69M.
  • Its year-over-year change of +0.0% is the 6th highest of 9, against a peer median of +0.6%.
  • Common stock amounts to 0.0% of total assets for PEN, versus a peer median of 0.1%.
PEN Competitors Peer median
Common Stock for PEN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ABTAbbott LaboratoriesJun 2026$25.5B +0.8%+1.1%23.3%
MMSIMerit Medical Systems, Inc.Sep 2026$808.93M +8.3%+4.2%—
EWEdwards Lifesciences CorporationJun 2026$661.7M +0.6%+0.6%4.8%
BSXBoston Scientific CorporationJun 2026$17M +0.0%+0.0%0.0%
ANGOAngioDynamics, Inc.Feb 2026$387K +0.5%+0.4%0.1%
ISRGIntuitive Surgical, Inc.Sep 2026$300K -25.0%+0.0%0.0%
LMATLeMaitre Vascular, Inc.Mar 2026$245K +1.2%+1.0%0.0%
PENPenumbra, Inc.Jun 2026$39K +0.0%+0.9%0.0%
MDTMedtronic plcJul 2026-$247M -782.1%—0.3%
Peer median (excluding PEN) $8.69M+0.6%+0.6%0.1%

Competitors are the stored peer set for PEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents59.38M69.86M167.49M324.4M186.9M
Short-term Investments195.5M118.17M121.7M15.73M357.92M
Net Receivables133.94M203.38M201.77M167.67M190.02M
Inventory263.5M334.01M388.02M406.74M431.55M
Other Current Assets2.4M30.28M36.42M36.59M50.3M
Total Current Assets681.47M755.7M915.4M951.13M1.22B
Property, Plant & Equipment (Net)227.09M280.41M280.5M267.76M316.35M
Goodwill166.39M166.05M166.27M165.83M166.75M
Intangible Assets90.62M91.72M83.1M7.2M6.83M
Long-term Investments00000
Tax Assets65.7M64.21M85.16M100.33M79.19M
Other Non-current Assets12.99M12.79M25.88M40.94M40.72M
Total Non-current Assets562.78M615.19M640.9M582.06M609.84M
Total Assets1.24B1.37B1.56B1.53B1.83B
Account Payables13.42M26.68M27.16M31.33M34.74M
Short-term Debt00000
Tax Payables00000
Deferred Revenue09.16M6.99M940K0
Other Current Liabilities000(940K)0
Total Current Liabilities123.2M144.93M151.14M158.35M183.13M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities3.56M3.28M5.31M15.11M12.32M
Total Non-current Liabilities167.13M227.1M226.22M223.91M215.78M
Total Liabilities290.32M372.03M377.36M382.25M398.92M
Common Stock37K38K39K38K39K
Retained Earnings45.91M43.9M134.86M60M237.69M
Accumulated OCI(2.63M)(8.12M)(3.15M)(5.84M)4.35M
Other Stockholders Equity00000
Minority Interest00000
Total Equity953.93M998.86M1.18B1.15B1.43B
Total Debt173.55M235.77M234.34M223.39M219.7M
Net Debt114.17M165.92M66.86M(101.02M)32.8M

Penumbra, Inc.

NYSE:PEN

Intrinsic Alpha fair value

Locked

Current Price

$320.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.